Cerity Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Sell |
12,812
-5,793
| -31% | -$480K | ﹤0.01% | 1488 |
|
|
2025
Q1 | $1.51M | Buy |
18,605
+1,016
| +6% | +$82.4K | ﹤0.01% | 1240 |
|
|
2024
Q4 | $1.6M | Buy |
17,589
+1,590
| +10% | +$145K | ﹤0.01% | 1203 |
|
|
2024
Q3 | $1.58M | Sell |
15,999
-558
| -3% | -$55.1K | ﹤0.01% | 1195 |
|
|
2024
Q2 | $1.54M | Sell |
16,557
-43,673
| -73% | -$4.05M | ﹤0.01% | 1035 |
|
|
2024
Q1 | $5.72M | Sell |
60,230
-2,208
| -4% | -$210K | 0.02% | 611 |
|
|
2023
Q4 | $5.58M | Sell |
62,438
-19,810
| -24% | -$1.77M | 0.02% | 510 |
|
|
2023
Q3 | $6.01M | Sell |
82,248
-1,362
| -2% | -$99.5K | 0.03% | 384 |
|
|
2023
Q2 | $6.96M | Buy |
83,610
+72,664
| +664% | +$6.05M | 0.03% | 427 |
|
|
2023
Q1 | $30.7M | Buy |
10,946
+369
| +3% | +$1.03M | 0.07% | 180 |
|
|
2022
Q4 | $877K | Buy |
10,577
+6,915
| +189% | +$574K | 0.01% | 732 |
|
|
2022
Q3 | $291K | Buy |
+3,662
| New | +$291K | ﹤0.01% | 904 |
|
|
2022
Q2 | – | Sell |
-2,302
| Closed | -$207K | – | 1247 |
|
|
2022
Q1 | $207K | Buy |
+2,302
| New | +$207K | ﹤0.01% | 858 |
|
|
2021
Q4 | – | Sell |
-1,588
| Closed | -$200K | – | 1051 |
|
|
2021
Q3 | $200K | Sell |
1,588
-1,075
| -40% | -$135K | ﹤0.01% | 651 |
|
|
2021
Q2 | $361K | Hold |
2,663
| – | – | 0.01% | 532 |
|
|
2021
Q1 | $361K | Buy |
2,663
+600
| +29% | +$81.3K | 0.01% | 507 |
|
|
2020
Q4 | $290K | Buy |
+2,063
| New | +$290K | 0.01% | 529 |
|
|
2018
Q1 | – | Sell |
-3,130
| Closed | -$266K | – | 588 |
|
|
2017
Q4 | $266K | Hold |
3,130
| – | – | 0.02% | 473 |
|
|
2017
Q3 | $271K | Buy |
3,130
+200
| +7% | +$17.3K | 0.02% | 462 |
|
|
2017
Q2 | $226K | Hold |
2,930
| – | – | 0.02% | 323 |
|
|
2017
Q1 | $203K | Buy |
+2,930
| New | +$203K | 0.02% | 415 |
|